logo-loader
viewArcturus Therapeutics

Arcturus Therapeutics sees 2020 as a transformative year for company

Arcturus Therapeutics Inc (NASDAQ: ARCT) CEO Joe Payne sat down with Proactive's Steve Darling at the 12th annual LD Micro Conference in Bel Air. The San Diego-based company is developing a portfolio of RNA therapeutics for the treatment of diseases with high unmet medical needs. According to the company, RNAs play crucial roles during disease progression and represent a diverse and largely untapped class of biomolecules that can be exploited for drug development

Quick facts: Arcturus Therapeutics

Price: 11.67 USD

NASDAQ:ARCT
Market: NASDAQ
Market Cap: $176.66 m
Follow

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

FOR OUR FULL DISCLAIMER CLICK HERE

Watch

Buds & Duds: Cannabis stocks finish week in the red; Canaccord initiates...

The North American Marijuana Index, which tracks the top cannabis stocks in the US and Canada, was down 2.6% higher at 117.4 points. Elsewhere, the OTCQX Cannabis index fell 1.8% to 480.1 points. Buds today were Pharmacielo Ltd (CVE:PCLO), The Valens Company (CVE:VLNS) (OTCMKTS:VLNCF)....

2 days, 11 hours ago

2 min read